Japanese journal of clinical oncology
-
Jpn. J. Clin. Oncol. · May 2010
Multicenter Study Comparative StudyDevelopment of a predicting tool for survival of terminally ill cancer patients.
To develop a predicting tool for survival of terminally ill cancer patients. ⋯ Japan Palliative Oncology Study-Prognostic Index, a tool to predict survival, has been developed. Its reliability should be confirmed further in the future study, comparing with palliative prognostic score.
-
Jpn. J. Clin. Oncol. · May 2010
A computer-assisted model for predicting probability of dying within 7 days of hospice admission in patients with terminal cancer.
The aim of the present study is to compare the accuracy in using laboratory data or clinical factors, or both, in predicting probability of dying within 7 days of hospice admission in terminal cancer patients. ⋯ We proposed a computer-assisted estimated probability formula for predicting dying within 7 days of hospice admission in terminal cancer patients.
-
Jpn. J. Clin. Oncol. · May 2010
Comparative StudyTrends for the past 10 years and international comparisons of the structure of Korean radiation oncology.
Study aims include determination of nationwide structural characteristics of radiation oncology facilities, types of radiation therapy equipment, availability of human resources and trends and comparisons with previous surveys. ⋯ This study will assist preparation of the administrative planning policy of radiation oncology and should be useful to indicate the direction of future development and educational training programs in Korea and possibly in other countries.
-
Jpn. J. Clin. Oncol. · May 2010
Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.
To examine the effects of dose-volume factors on the development of radiation pneumonitis in patients with non-small-cell lung cancer who received twice-daily radiotherapy concurrently with carboplatin and paclitaxel chemotherapy. ⋯ Several cut-off values in the V(dose) and the mean lung dose differentiating probabilities of developing > or = G2 radiation pneumonitis were identified in this combination therapy.